Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has entered into a definitive agreement to acquire Arcellx (Nasdaq: ACLX) for $115 per share in cash at closing and one contingent value ...
Once a loan is paid off, banks, credit unions and dealers can release the title immediately. Leaders say this benefits ...
CPD accredited public sector news, comment & analysis for Civil Servants responsible for building, shaping and delivering transformational public services. The UK's No1 Public Sector Magazine.
THE WEEK > Your government The meetings listed below are open to the public. Some of them can be observed by livestream.
Carlisle’s Miller falls to reigning state champion in final ...
Bristol Myers Squibb (NYSE: BMY) today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) evaluating Reblozyl® (luspatercept-aamt) versus placebo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results